Loading match intelligence
If the PTAB issues a final written decision in an inter partes review that invalidates all claims of a Moderna patent covering mRNA vaccine technology, then Yes. Otherwise No.
Resolves Yes if If the PTAB issues a final written decision in an inter partes review that invalidates all claims of a Moderna patent covering mRNA vaccine technology, then Yes. Otherwise No.
Outcome verified from uspto.gov.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…